Insider Transactions in Q4 2020 at Spruce Biosciences, Inc. (SPRB)
Insider Transaction List (Q4 2020)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 14
2020
|
Jonas Hansson Director |
BUY
Open market or private purchase
|
Indirect |
250,000
+10.95%
|
$3,750,000
$15.0 P/Share
|
Oct 14
2020
|
Jonas Hansson Director |
BUY
Conversion of derivative security
|
Indirect |
1,783,621
+50.0%
|
-
|
Oct 14
2020
|
Health Cap Viii, L.P. |
BUY
Open market or private purchase
|
Direct |
250,000
+10.95%
|
$3,750,000
$15.0 P/Share
|
Oct 14
2020
|
Health Cap Viii, L.P. |
BUY
Conversion of derivative security
|
Direct |
1,783,621
+50.0%
|
-
|
Oct 14
2020
|
Moghrabi Dina Chaya Director |
BUY
Open market or private purchase
|
Indirect |
250,000
+10.37%
|
$3,750,000
$15.0 P/Share
|
Oct 14
2020
|
Moghrabi Dina Chaya Director |
BUY
Conversion of derivative security
|
Indirect |
1,911,022
+50.0%
|
-
|
Oct 14
2020
|
Omega Fund Vi, L.P. |
BUY
Open market or private purchase
|
Direct |
250,000
+10.37%
|
$3,750,000
$15.0 P/Share
|
Oct 14
2020
|
Omega Fund Vi, L.P. |
BUY
Conversion of derivative security
|
Direct |
1,911,022
+50.0%
|
-
|
Oct 14
2020
|
Niall O'Donnell Director |
BUY
Open market or private purchase
|
Indirect |
250,000
+26.43%
|
$3,750,000
$15.0 P/Share
|
Oct 14
2020
|
Niall O'Donnell Director |
BUY
Conversion of derivative security
|
Indirect |
445,905
+50.0%
|
-
|
Oct 14
2020
|
Bali Muralidhar |
BUY
Open market or private purchase
|
Indirect |
200,000
+10.04%
|
$3,000,000
$15.0 P/Share
|
Oct 14
2020
|
Bali Muralidhar |
BUY
Conversion of derivative security
|
Indirect |
1,592,518
+50.0%
|
-
|
Oct 14
2020
|
River Vest Venture Fund Iii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
250,000
+10.42%
|
$3,750,000
$15.0 P/Share
|
Oct 14
2020
|
River Vest Venture Fund Iii, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,898,281
+40.19%
|
-
|
Oct 14
2020
|
Novo Holdings > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
250,000
+4.77%
|
$3,750,000
$15.0 P/Share
|
Oct 14
2020
|
Novo Holdings > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
4,739,336
+50.0%
|
-
|